Minakari [20] investigated the prevalence of hepatic steatosis in a group of 132 patients with chronic HBV Infection Steatosis, which was present in 42.4% of patients and was not associated with age, sex, HBeAg, viral load, fibrosis score, serum cholesterol level, aspartate amino transferase, alanine amino transferase and alkaline phosphatase. This evidence concerns the gene GPT and fatty liver disease.